These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 6153829

  • 1. Effects of PUVA on the epidermal melanocyte population in psoriatic patients.
    Rosdahl IK, Swanbeck G.
    Acta Derm Venereol; 1980; 60(1):21-6. PubMed ID: 6153829
    [Abstract] [Full Text] [Related]

  • 2. Nevus spilus-like hyperpigmentation in psoriatic lesions during PUVA therapy.
    Helland S, Bang G.
    Acta Derm Venereol; 1980; 60(1):81-3. PubMed ID: 6153845
    [Abstract] [Full Text] [Related]

  • 3. Psoralen-UVA-treated psoriatic lesions. Ultrastructural changes.
    Hashimoto K, Kohda H, Kumakiri M, Blender SL, Willis I.
    Arch Dermatol; 1978 May; 114(5):711-22. PubMed ID: 646392
    [Abstract] [Full Text] [Related]

  • 4. 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light.
    Hansson C, Rorsman H, Rosengren E, Tegner E.
    Acta Derm Venereol; 1981 May; 61(3):251-5. PubMed ID: 6167110
    [Abstract] [Full Text] [Related]

  • 5. Morphologic changes in epidermis of PUVA-treated patients with psoriasis with or without a history of arsenic therapy.
    Niemi KM, Niemi A, Kanerva L.
    Arch Dermatol; 1983 Nov; 119(11):904-9. PubMed ID: 6639110
    [Abstract] [Full Text] [Related]

  • 6. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
    Anbar TS, El-Sawy AE, Attia SK, Barakat MT, Moftah NH, El-Ammawy TS, Abdel-Rahman AT, El-Tonsy MH.
    Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
    [Abstract] [Full Text] [Related]

  • 7. Serum uric acid levels in untreated and PUVA-treated patients with psoriasis.
    Brenner W, Gschnait F.
    Acta Derm Venereol Suppl (Stockh); 1979 Feb; 87():41-2. PubMed ID: 294782
    [Abstract] [Full Text] [Related]

  • 8. PUVA-treated psoriatic skin as a model for cutaneous wrinkling assessed by skin replicas.
    Brazzelli V, Borroni G, Berardesca E, Romano E, Vignoli GP, Rabbiosi G.
    Acta Derm Venereol Suppl (Stockh); 1994 Feb; 186():162-3. PubMed ID: 8073823
    [Abstract] [Full Text] [Related]

  • 9. Resolution of psoriatic lesions in erythematous skin induced by PUVA treatment.
    Vukas A, Batistić B, Zambal Z.
    Acta Med Iugosl; 1979 Feb; 33(2):147-53. PubMed ID: 506793
    [No Abstract] [Full Text] [Related]

  • 10. DNA in psoriatic epidermis.
    Sondergaard J, Lerche A, Bohr V, Leik V, Wadskov S.
    Acta Derm Venereol Suppl (Stockh); 1979 Feb; 87():59-63. PubMed ID: 294785
    [Abstract] [Full Text] [Related]

  • 11. The pigmentary response to photochemotherapy.
    Zaynoun S, Konrad K, Gschnait F, Wolff K.
    Acta Derm Venereol; 1977 Feb; 57(5):431-40. PubMed ID: 73310
    [Abstract] [Full Text] [Related]

  • 12. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
    Trott J, Gerber W, Hammes S, Ockenfels HM.
    Eur J Dermatol; 2008 Feb; 18(1):55-60. PubMed ID: 18086590
    [Abstract] [Full Text] [Related]

  • 13. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach.
    Collins P, Wainwright NJ, Amorim I, Lakshmipathi T, Ferguson J.
    Br J Dermatol; 1996 Aug; 135(2):248-54. PubMed ID: 8881668
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of different treatment frequencies of psoralen and ultraviolet A in psoriatic patients with darker skin types (randomized-controlled study).
    El-Mofty M, El Weshahy H, Youssef R, Abdel-Halim M, Mashaly H, El Hawary M.
    Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):38-42. PubMed ID: 18201356
    [Abstract] [Full Text] [Related]

  • 15. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
    Legat FJ, Hofer A, Quehenberger F, Kahofer P, Kerl H, Wolf P.
    J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
    [Abstract] [Full Text] [Related]

  • 16. [Photochemotherapy for psoriatic patients treated with corticosteroids and methotrexate].
    Gschnait F, Konrad K, Hönigsmann H, Wolff K.
    Hautarzt; 1977 Dec; 28(12):632-7. PubMed ID: 599023
    [Abstract] [Full Text] [Related]

  • 17. Psoralens and UV-A and UV-B twice weekly for the treatment of psoriasis.
    Diette KM, Momtaz-T K, Stern RS, Arndt KA, Parrish JA.
    Arch Dermatol; 1984 Sep; 120(9):1169-73. PubMed ID: 6476854
    [Abstract] [Full Text] [Related]

  • 18. The influence of PUVA treatment on the substructure of nevocellular nevi in psoriatic patients.
    Lagerholm B, Frithz A.
    Acta Derm Venereol; 1982 Sep; 62(1):7-14. PubMed ID: 6175143
    [Abstract] [Full Text] [Related]

  • 19. [The Koebner phenomenon, a prognostic sign of PUVA therapy effectiveness in patients with psoriasis vulgaris--yes or no?].
    Matović L, Poljacki M, Duran V, Stojanović S, Subotić M.
    Med Pregl; 1999 Sep; 52(11-12):437-40. PubMed ID: 10748764
    [Abstract] [Full Text] [Related]

  • 20. Prostaglandins in PUVA-treated psoriasis.
    Heiligstädt H, Kassis B, Weismann K, Søndergaad J.
    Acta Derm Venereol; 1978 Sep; 58(3):213-6. PubMed ID: 78634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.